Smartwatches track hidden heart risk in blood cancer patients
Knowledge-focused
Not yet recruiting
This study investigates how often atrial fibrillation (AF), a type of irregular heartbeat, occurs in people with certain blood cancers who are starting a targeted cancer drug called a Bruton's tyrosine kinase inhibitor (BTKI). Researchers will follow 500 participants—400 starting…
Sponsor: Tina Baykaner • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC